mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.24 |
7e-06 |
mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.23 |
8e-06 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
1e-05 |
mRNA |
paclitaxel |
gCSI |
pan-cancer |
AAC |
0.22 |
2e-05 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
2e-05 |
mRNA |
MST-312 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
2e-05 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
4e-05 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
5e-05 |